Julian Chick

Dr. Julian Chick has over 20 years’ experience in capital markets and LSHC, on both the investor and operational side of businesses, giving him a unique understanding of companies’ value drivers, value inflection points and commercialisation strategies and pathways.

Included in his roles, Julian has worked in funds management and venture capital and private funding. Julian’s funds under management grew from $115 million to over $300 million over a 5-year period, with an average annual return of over 20%.

Julian has spent the past 15 years at an Executive level of life sciences companies across therapeutics, diagnostics and medical devices (including 8 early stage and start-up companies and achieved one trade sale exit of an Australian contract services organisation), multiple IPOs and public offerings in Australia and Singapore, 3 global product approvals (including through the US Food and Drug Administration and the European Medicines Agency) and launches.

Julian has raised over $300 million globally for LSHC companies and has an in-depth understanding across the LSHC sectors.

Julian has a PhD in Physiology from La Trobe University and Oxford University and is an Adjunct Professor at Monash University.